Histopathological examination revealed-Non Hodgkin's Lymphoma (High Grade).
Discussion
A case of primary Non-Hodgkin's lymphoma of the larynx is presented with a review of the literature. Non-Hodgkin's lymphomas with primary laryngeal presentation is very rare. The symptoms usually include dysphonia and progressive airway obstruction requiring tracheostomy.
Laryngeal Non-Hodgkin's lymphomas are of B cell lineage and respond well to radiotherapy. Our patient had a high grade lymphoma of B cell lineage which showed a good response to radiotherapy. The role of chemotherapy and surgery is not yet established [
6]. Primary localised laryngeal lymphoma is rare. The presenting symptoms are hoarseness of voice of long duration and increasing dyspnoea. Clinical and histological diagnosis is difficult and in some cases repeated biopsies are needed for conclusive diagnosis. Radiotherapy appears to be the treatment of choice for the disease. As in addition there may be head, neck or distant localisations, there should be a complete clinical evaluation before treatment, including lymphangiography, IV pyelography, liver and spleen scans, and total body CT scan. Although in a significant number of cases laryngeal lymphoma has been cured or has remained a localized disease, it is very likely that in some cases additional treatment for the tumour at other sites may be required. Lifelong follow-up and careful periodic evaluation by experts is imperative.
Primary laryngeal lymphoma is a very rare entity, with fewer than 50 cases reported in the English literature in the past 60 years. Close scrutiny of some of these case reports reveal that the larynx was not always the only site of involvement, thereby diminishing the total number of patients with primary laryngeal lymphoma to fewer than 35. In view of the heterogeneity of histologies in this group of lymphomas, the variability in duration of response, and the significant number of patients who died of their disease, it is more likely that primary laryngeal lymphoma is an unusual presentation of non-Hodgkin's lymphoma than a separate disease entity. Despite the small number of patients in this study, the data would suggest that patients are best treated according to the histology of the lymphoma, rather than the limited stage and location of the disease [
7].
The biologic behaviour of these tumors has many features in common with other extranodal lymphomas arising from mucosa-associated lymphoid tissue (e.g., a tendency to remain localised for long periods of time and to disseminate to other extranodal and unusual sites, with good response to radiotherapy for both the primary tumour and extranodal recurrences).